240 related articles for article (PubMed ID: 25656992)
1. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis.
Zhao L; Li W; Zhou Y; Zhang Y; Huang S; Xu X; Li Z; Guo Q
Free Radic Biol Med; 2015 May; 82():29-41. PubMed ID: 25656992
[TBL] [Abstract][Full Text] [Related]
2. GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway.
Zhao Y; Sun Y; Ding Y; Wang X; Zhou Y; Li W; Huang S; Li Z; Kong L; Guo Q; Lu N
Oncotarget; 2015 Sep; 6(28):26291-307. PubMed ID: 26327408
[TBL] [Abstract][Full Text] [Related]
3. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
4. Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway.
Malik G; Gorbounov N; Das S; Gurusamy N; Otani H; Maulik N; Goswami S; Das DK
Antioxid Redox Signal; 2006; 8(11-12):2101-9. PubMed ID: 17034353
[TBL] [Abstract][Full Text] [Related]
5. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
[TBL] [Abstract][Full Text] [Related]
6. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
7. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
8. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
9. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
Wei SJ; Botero A; Hirota K; Bradbury CM; Markovina S; Laszlo A; Spitz DR; Goswami PC; Yodoi J; Gius D
Cancer Res; 2000 Dec; 60(23):6688-95. PubMed ID: 11118054
[TBL] [Abstract][Full Text] [Related]
11. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
Zhang X; Kang Y; Huo T; Tao R; Wang X; Li Z; Guo Q; Zhao L
Free Radic Biol Med; 2017 Nov; 112():49-59. PubMed ID: 28697922
[TBL] [Abstract][Full Text] [Related]
12. LW-214, a newly synthesized flavonoid, induces intrinsic apoptosis pathway by down-regulating Trx-1 in MCF-7 human breast cells.
Pan D; Li W; Miao H; Yao J; Li Z; Wei L; Zhao L; Guo Q
Biochem Pharmacol; 2014 Feb; 87(4):598-610. PubMed ID: 24374359
[TBL] [Abstract][Full Text] [Related]
13. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer.
Gu J; Li Y; Zeng J; Wang B; Ji K; Tang Y; Sun Q
Sci Rep; 2017 Aug; 7(1):7546. PubMed ID: 28790395
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: inactivation of ribonucleotide reductase and redox-mediated checkpoint control.
Muniyappa H; Song S; Mathews CK; Das KC
J Biol Chem; 2009 Jun; 284(25):17069-17081. PubMed ID: 19369702
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-1 phosphorylated at T100 is needed for its anti-apoptotic activity in HepG2 cancer cells.
Chen X; Tang W; Liu S; Yu L; Chen Z
Life Sci; 2010 Aug; 87(7-8):254-60. PubMed ID: 20619274
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
20. Spatio-temporal changes in glutathione and thioredoxin redox couples during ionizing radiation-induced oxidative stress regulate tumor radio-resistance.
Patwardhan RS; Sharma D; Checker R; Thoh M; Sandur SK
Free Radic Res; 2015 Oct; 49(10):1218-32. PubMed ID: 26021764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]